RxDoctor Payments Data

Amber Gordon, MD

Neurological Surgery · Mobile, ALNPI 1225299589

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (47.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 43 manufacturers reported payments, led by Spineology Inc. at 42.3% of the total. 2025 is the largest year on record at $12,620, 8.3 times the $1,522 reported in 2019.

$23,744in general payments, 2019–2025

Across 230 payments — averaging $103.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Spineology Inc.$10K
  • Baxter Healthcare$5K
  • Providence Medical Technology, Inc.$3K
  • Johnson & Johnson$820
  • Brainlab, Inc.$804
  • Si-bone, Inc.$540
  • plus $3K from 37 others

What the payments were for

  • Consulting fees$11,21047%
  • Speaking & faculty fees$2411%
  • Travel & lodging$3,20013%
  • Food & beverage$9,02938%
  • Entertainment$650%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$23,744 in reported general payments places this provider in the 85th percentile of 97 neurological surgery providers in Alabama.

See all neurological surgery providers in Alabama

Medicare billing

Part B allowed, 2024
$46,609
Medicare patients
131
Services billed
294

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methocarbamol30$204
Gabapentin15$178
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen21$143
Cyclobenzaprine Hcl11$130
Meloxicam16$70
Diazepam17$33

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Mobile

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →